Prevalence of anti-SARS-CoV-2 antibodies and associated factors in healthcare workers of a Mexican Covid-19 hospital

被引:1
|
作者
Herrera-Ortiz, Antonia [1 ]
Ugo Rojas-Delgado, Hector [2 ]
Garcia-Cisneros, Santa [1 ]
Xibille-Friedmann, Daniel X. [2 ]
Martinez-Barnetche, Jesus [1 ]
Olamendi-Portugal, Maria [1 ]
Minerva Gonzalez-Sanchez, Hilda [1 ,3 ]
Angel Sanchez-Aleman, Miguel [1 ]
机构
[1] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico
[2] Hosp Gen Dr Jose G Parres, Cuernavaca, Morelos, Mexico
[3] Conacyt Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico
来源
SALUD PUBLICA DE MEXICO | 2022年 / 64卷 / 04期
关键词
SARS-CoV-2; healthcare workers; antibodies; seroprevalence; SARS-COV-2; ANTIBODIES; SEROPREVALENCE;
D O I
10.21149/13677
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective. To determine the prevalence of SARS-CoV-2 antibodies among healthcare workers (HCW) and to identify factors associated with infection. Materials and methods. A cross-sectional study was conducted in a Covid-19 hospital in Morelos, Mexico. Antibodies against SARS-CoV-2 spike and nucleocapsid proteins were detected by ELISA.A bivariate and multivariable Poisson regression model were performed to identify factors associated with infection. Results.Among all participants, 31% had anti-SARS-CoV-2 antibodies, while only 13.1% had reported a history of positive RT-PCR. Individuals who reported cohabiting with someone with Covid-19, and those who had a previous RT-PCR test, were more likely to be seropositive. Laboratory personnel had the lowest seroprevalence (12.0%), while social workers had the highest (35.7%). Conclusions. The results of this study show the seroprevalence of SARS-CoV-2 antibodies among HCW in a hospital in Mexico, and underline the importance of serological tests for a better estimate of prevalence in health systems where only symptomatic cases are recorded.
引用
收藏
页码:348 / 356
页数:9
相关论文
共 50 条
  • [21] Prevalence of Anti-SARS-CoV-2 Antibodies and Associated Factors Among Health Care Workers in Santiago De Cali, Colombia
    Osorio-Toro, Luis Miguel
    Bonilla-Bonilla, Diana Marcela
    Daza-Arana, Jorge Enrique
    Aristizabal, Juan Carlos
    Avila-Valencia, Juan Carlos
    Ramirez-Marmolejo, Roberto
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 697 - 705
  • [22] Evaluation of Anti-SARS-CoV-2 IgG Antibody in Healthcare Professionals Infected with COVID-19
    Moradveisi, Borhan
    Behzadi, Shirin
    Zakaryaei, Farima
    Jalili, Ali
    Rahmani, Khaled
    Karimi, Avat
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2021, 14 (11)
  • [23] Anti-SARS-CoV-2 Antibodies Level and COVID-19 Vaccine Boosters among Healthcare Workers with the Highest SARS-CoV-2 Infection Risk-Follow Up Study
    Lorent, Dagny
    Nowak, Rafal
    Figlerowicz, Magdalena
    Handschuh, Luiza
    Zmora, Pawel
    VACCINES, 2024, 12 (05)
  • [24] Seroprevalence of anti-SARS-CoV-2 antibodies and associated factors among household contacts of COVID-19 confirmed cases in Bangkok, Thailand
    Atsawawaranunt, Kamolthip
    Thiangthangthum, Khammakorn
    Sirikhetkon, Somrak
    Jampathong, Promporn
    Kongklieng, Amornmas
    Nakphook, Sutthichai
    Phonsingh, Poolsap
    Yorsaeng, Ritthideach
    Praphasiri, Prabda
    Mungaomklang, Anek
    HELIYON, 2023, 9 (05)
  • [25] Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in Guinea
    Grayo, Solene
    Sagno, Houlou
    Diassy, Oumar
    Zogbelemou, Jean-Baptiste
    Kondabo, Sia Jeanne
    Houndekon, Marilyn
    Dellagi, Koussay
    Vigan-Womas, Ines
    Rourou, Samia
    Hamouda, Wafa Ben
    Benabdessalem, Chaouki
    Ahmed, Melika Ben
    Tordo, Noel
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [26] Kinetics of Anti-SARS-CoV-2 IgG among healthcare workers in a General Hospital
    Leli, Christian
    Callegari, Tiziana
    Cassinari, Maurizio
    Rocchetti, Andrea
    NEW MICROBIOLOGICA, 2021, 44 (02): : 84 - 88
  • [27] Unexpected Detection of Anti-SARS-CoV-2 Antibodies Before the Declaration of the COVID-19 Pandemic
    Mahallawi, Waleed
    Ibrahim, Nadir
    FRONTIERS IN MEDICINE, 2022, 9
  • [28] Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients
    Lee, Yu-Lin
    Liao, Chia-Hung
    Liu, Po-Yu
    Cheng, Chien-Yu
    Chung, Ming-Yi
    Liu, Chun-Eng
    Chang, Sui-Yuan
    Hsueh, Po-Ren
    JOURNAL OF INFECTION, 2020, 81 (02) : E55 - E58
  • [29] Correspondence on anti-SARS-CoV-2 antibodies and clinical outcome of hospitalized COVID-19 patients
    Kleebayoon, Amnuay
    Wiwanitkit, Viroj
    MEDICINA CLINICA, 2023, 161 (07): : 315 - 315
  • [30] Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
    Alharbi, Naif Khalaf
    Al-Tawfiq, Jaffar A.
    Alwehaibe, Amal
    Alenazi, Mohamed W.
    Almasoud, Abdulrahman
    Algaisi, Abdullah
    Alhumaydhi, Fahad A.
    Hashem, Anwar M.
    Bosaeed, Mohammed
    Alsagaby, Suliman A.
    INFECTION AND DRUG RESISTANCE, 2022, 15 : 4127 - 4136